• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $VHAQ

    Viveon Health Acquisition Corp.

    Subscribe to $VHAQ
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viveon Health Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Norcross, Georgia.

    IPO Year: 2021

    Exchange: AMEX

    Recent Analyst Ratings for Viveon Health Acquisition Corp.

    DatePrice TargetRatingAnalyst
    See more ratings

    Viveon Health Acquisition Corp. SEC Filings

    View All

    SEC Form 425 filed by Viveon Health Acquisition Corp.

    425 - Viveon Health Acquisition Corp. (0001823857) (Subject)

    7/19/24 5:01:10 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Viveon Health Acquisition Corp.

    8-K - Viveon Health Acquisition Corp. (0001823857) (Filer)

    7/19/24 5:00:45 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 25-NSE filed by Viveon Health Acquisition Corp.

    25-NSE - Viveon Health Acquisition Corp. (0001823857) (Subject)

    7/10/24 9:51:56 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Viveon Health Acquisition Corp.

    10-Q - Viveon Health Acquisition Corp. (0001823857) (Filer)

    6/6/24 5:01:12 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 425 filed by Viveon Health Acquisition Corp.

    425 - Viveon Health Acquisition Corp. (0001823857) (Subject)

    6/5/24 4:36:05 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viveon Health Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Viveon Health Acquisition Corp. (0001823857) (Filer)

    6/5/24 4:35:13 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 425 filed by Viveon Health Acquisition Corp.

    425 - Viveon Health Acquisition Corp. (0001823857) (Subject)

    4/1/24 4:46:18 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viveon Health Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Viveon Health Acquisition Corp. (0001823857) (Filer)

    4/1/24 4:45:50 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form NT 10-K filed by Viveon Health Acquisition Corp.

    NT 10-K - Viveon Health Acquisition Corp. (0001823857) (Filer)

    3/29/24 8:00:26 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 425 filed by Viveon Health Acquisition Corp.

    425 - Viveon Health Acquisition Corp. (0001823857) (Subject)

    3/27/24 6:39:35 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viveon Health Acquisition Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Viveon Health Acquisition Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    SEC Form 4 filed by Logothetis Demetrios G.

    4 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    6/4/21 3:45:58 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4: Viveon Health, LLC decreased direct ownership by 0.55% to 4,923,250 units

    4 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    6/3/21 5:47:20 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3: Logothetis Demetrios G. claimed no ownership of Common Stock

    3 - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    5/12/21 8:38:37 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Llc Health, Viveon (Amendment)

    4/A - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    4/8/21 4:25:28 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Romilos Papadopoulos (Amendment)

    4/A - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    4/8/21 4:23:28 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Jagi Gill (Amendment)

    4/A - Viveon Health Acquisition Corp. (0001823857) (Issuer)

    4/8/21 4:22:20 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success

    San Antonio, TX, May 02, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would like to thank Jeffrey Coleman for his services as a Board Member to Clearday since its merger back in September 2021. James Walesa, CEO and Founder of Clearday, said, "Jeff has been a staunch supporter of the cause of innovating Senior Care for years. He has brought wisdom and experience to our Board over the last three (3) years. We know Jeff will be an asset to his next company. We wish him well in his new endeavors and feel confident that he will be met with great success." Clearday seeks

    5/2/24 2:15:00 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESS

    New York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") re-affirms its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. The Company is focused on completing all of its regulatory filings to support completing the business combination with Clearday. Additionally, the Company will be appealing the recent decision by a hearings panel of the NYSE American's Committee for Review confirming the decision by the NYSE Staff to delist the Company's units, common stock and rights. As a result of that decisi

    2/27/24 4:45:00 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION

    Viveon combination with Clearday continues to move forward New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE:VHAQ, VHAQW, VHAQR, VHAQU))) a special purpose acquisition company (the "Company") today is pleased to reconfirm its commitment to the previously announced business combination with Clearday (CLRD-OTCQX), a San Antonio, Texas-based Healthcare Services company. Clearday's mission is to bring digital companionship to the 170 million Americans turning 50 by 2030. The companies, together with their financial advisor, ClearThink Capital, have been working diligently on the transaction and look forward to continuing to work with ClearThink after the propose

    2/1/24 9:30:00 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE

    Atlanta, GA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ, VHAQW, VHAQR, VHAQU the "Company"))) announces that, as previously disclosed in the Current Report on Form 8-K filed on December 26, 2023 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC ("NYSE American" or the "Exchange") on December 22, 2023, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company's Common Stock, Units and Rights (collectively, the "Securities") pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business

    12/27/23 5:23:00 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VIVEON HEALTH ACQUISITION CORP. RECEIVED AUDIT OPINION WITH GOING CONCERN EXPLANATION

    ATLANTA, GEORGIA, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) ("Viveon" or the "Company") announced today that, as previously disclosed in its annual report on Form 10-K for the fiscal year ended December 31, 2022, which was filed on August 24, 2023 with the U.S. Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company's ability to continue as a going concern. See further discussion in Note 1 to the Company's financial statements included

    9/15/23 4:49:57 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viveon Healthcare Increases Consideration Offered to Clearday Shareholders

    In Amendment to the Definitive Merger Agreement Clearday Receives Higher Valuation San Antonio, Texas, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (OTCQX:CLRD), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, is pleased to announce an amendment to the Definitive Merger Agreement previously signed on April 5, 2023, issued by Viveon Healthcare Acquisition Corporation (NYSE:VHAQ) ("Viveon"). Viveon confirmed its commitment to the merger and increased Clearday's valuation. Viveon and Clearday continue to work to close the merger. James Walesa, CEO of Clearday, said, "Th

    9/5/23 8:30:00 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement

    Norcross GA and San Antonio, TX, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon"), a special purpose acquisition company, and Clearday, Inc. (CLRD) ("Clearday"), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, announced today that they have amended the terms of their previously announced Merger Agreement, dated as of April 5, 2023 (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, a business combination between Viveon and Clearday will be effected through the merger of a wholly owned subsidiary of Viveon with and int

    8/29/23 10:45:00 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VIVEON HEALTH ACQUISITION CORP. RECEIVES NYSE NOTICE REGARDING DELAYED FORM 10-K FILING

    New York, April 25, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) (the "Company") announced today, that on April 18, 2023, the Company received a notice letter (the "Notice") from the NYSE Regulation Department (the "Staff") of the New York Stock Exchange American ("NYSE") notifying the Company that, based upon the Company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the "Annual Report"), it was not in compliance with the NYSE American's continued listing requirements. Pursuant to the Notice, the Company has six (6) months, to file its Annual Repor

    4/25/23 4:20:00 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    (Updated) Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to Market

    CEO Jim Walesa will lead the combined company, Clearday, as Chief Executive OfficerJagi Gill, Chief Executive Officer and Chairman of Viveon Health, will join the Board of Directors of Clearday  San Antonio, Texas, April 12, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (CLRD) ("Clearday" or the "Company"), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, announced that they have entered into a definitive merger agreement. Company Overview Clearday is transitio

    4/12/23 8:00:00 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to Market

    CEO Jim Walesa will lead the combined company, Clearday, as Chief Executive Officer Jagi Gill, Chief Executive Officer and Chairman of Viveon Health, will join the Board of Directors of Clearday San Antonio, Tx and Norcross, GA, April 06, 2023 (GLOBE NEWSWIRE) -- Clearday, Inc. (CLRD) ("Clearday" or the "Company"), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp. (NYSE:VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, announced today that they have entered into a definitive merger agreement. Company Over

    4/6/23 6:30:00 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viveon Health Acquisition Corp. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/14/24 4:56:17 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/14/24 1:18:24 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/12/24 11:08:50 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/16/23 4:52:25 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Viveon Health Acquisition Corp.

    SC 13G - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/14/23 4:44:47 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Viveon Health Acquisition Corp.

    SC 13G - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/14/23 7:34:52 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/10/23 4:29:02 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Viveon Health Acquisition Corp.

    SC 13G - Viveon Health Acquisition Corp. (0001823857) (Subject)

    2/10/23 4:00:31 PM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Viveon Health Acquisition Corp. (Amendment)

    SC 13G/A - Viveon Health Acquisition Corp. (0001823857) (Subject)

    11/14/22 9:15:37 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Viveon Health Acquisition Corp.

    SC 13G - Viveon Health Acquisition Corp. (0001823857) (Subject)

    8/1/22 8:07:50 AM ET
    $VHAQ
    Biotechnology: Pharmaceutical Preparations
    Health Care